A systematic review and meta-analysis Annals of Oncology, 03/25/2014 Review Article Schmid D, et al. – Using prospective studies published through June 2013, the authors conducted a systematic review and random–effects meta–analysis of pre– and post–diagnosis physical activity in relation to total and cancer mortality among breast or colorectal cancer survivors. Physical activity performed before or after […]
A systematic review and meta-analysis Annals of Oncology, 03/25/2014 Review Article Schmid D, et al. – Using prospective studies published through June 2013, the authors conducted a systematic review and random–effects meta–analysis of pre– and post–diagnosis physical activity in relation to total and cancer mortality among breast or colorectal cancer survivors. Physical activity performed before […]
Fran Lowry March 13, 2014 Women with high levels of vitamin D in their blood when they are diagnosed with breast cancer are almost twice as likely to survive as those with low levels of vitamin D, according to a meta-analysis published in the March issue of Anticancer Research. The meta-analysis looked at 5 studies of serum 25-hydroxyvitamin D (25[OH]D) […]
European Journal of Cancer, 03/04/2014 Evidence Based Medicine Review Article Clinical Article PubMed Reference Maalmi H, et al. – This studya ims to estimate the association between serum 25–hydroxyvitamin D (25(OH)D) levels and survival among colorectal and breast cancer patients. Higher 25(OH)D levels (>75nmol/L) were associated with significantly reduced mortality in patients with colorectal and breast cancer. […]
by Melissa Healy February 15, 2014 A team of researchers from the City of Hope in Duarte has developed a speedy way to identify drugs and chemicals that can disrupt the balance of sex hormones in human beings and influence the development and progress of diseases such as breast cancer. In a trial screening of […]
Published: Feb 11, 2014 | Updated: Feb 13, 2014 By Charles Bankhead, Staff Writer, MedPage Today Full Story Action Points Annual mammography failed to reduce breast cancer mortality in women, ages 40 to 59, compared with physical examination or routine care, based on 25-year follow-up data from a Canadian screening program. Point out that the […]
Roxanne Nelson February 11, 2014 The value of screening mammograms for detecting breast cancer and reducing mortality has been fiercely debated. Studies have come to conflicting conclusions, and a new study showing that mammography has no effect on breast cancer deaths will undoubtedly fan the fires once again. The Canadian researchers conclude that annual screening […]
J. Natl. Cancer Inst 2013 Dec 07;[EPub Ahead of Print], JP Pierce, RE Patterson, CM Senger, SW Flatt, BJ Caan, L Natarajan, SJ Nechuta, EM Poole, XO Shu, WY Chen Research · January 01, 2014 TAKE-HOME MESSAGE In this analysis of women with a history of breast cancer and tobacco use, the authors report an increase […]
Published: Dec 19, 2013 | Updated: Dec 20, 2013 By Salynn Boyles, Contributing Writer, MedPage Today Action Points Note that this dietary-intervention trial revealed that a tomato-rich diet increased serum concentrations of adiponectin among women at elevated risk of breast cancer. Be aware that, as incidence of breast cancer was not captured, it would be […]
Maturitas. 2014 Mar;77(3):202-8. doi: 10.1016/j.maturitas.2013.11.010. Epub 2013 Dec 11. Baena Ruiz R, Salinas Hernández P. Abstract BACKGROUND: Diet represents 30-35% of risk factors that contribute to the onset of cancer. Some foods and dietary patterns have been linked to the risk of various cancers. However epidemiological available data are not consistent for many foods and […]
Link LB Abstract BACKGROUND: Evidence that diet is associated with breast cancer risk is inconsistent. Most studies have examined risks associated with specific foods and nutrients, rather than measures of overall diet. OBJECTIVE: This study aimed to evaluate dietary patterns and their relation to breast cancer risk in a large cohort of women. DESIGN: Data […]
Women who are carriers of BRCA1/2 mutations were found to have higher levels of circulating progesterone and estrogen compared with BRCA1/2-negative women. This may be a contributing factor to an increased risk of breast and ovarian cancer among BRCA-positive women.
JAMA 2013 Oct 01;310(13)1353-1368, JE Manson, RT Chlebowski, ML Stefanick, AK Aragaki, JE Rossouw, RL Prentice, G Anderson, BV Howard, CA Thomson, AZ Lacroix, J Wactawski-Wende, RD Jackson, M Limacher, KL Margolis, S Wassertheil-Smoller, SA Beresford, JA Cauley, CB Eaton, M Gass, J Hsia, KC Johnson, C Kooperberg, LH Kuller, CE Lewis, S Liu, LW […]
Published: Oct 10, 2013 | Updated: Oct 11, 2013 By Charles Bankhead, Staff Writer, MedPage Today Full Story: http://www.medpagetoday.com/HematologyOncology/BreastCancer/42208 Postmenopausal breast cancer patients had a significantly lower risk of dying of the disease if they consumed multivitamins with minerals, an analysis of data from the Women’s Health Initiative (WHI) showed. Overall, use of multivitamins with […]
Laurie Barclay, MD Oct 04, 2013 Full Medscape Article: http://www.medscape.com/viewarticle/812116 Walking for 1 hour or more daily was associated with a 14% lower risk for breast cancer, and high physical activity was associated with a 25% lower risk, compared with the risk for most sedentary women, according to findings from a large prospective study published […]
Be aware that while estrogen plus progestin therapy may increase the risk of breast cancer, this evidence suggests that estrogen therapy alone may carry some protection against breast cancer for women without a uterus.
Daniel M. Keller, PhD Sep 26, 2013 VIENNA, Austria — One fifth of all people with a mitochondrial disorder (MID) develop a neoplasm, a new study shows. Somehow, derangements in these microscopic powerhouses of the cell confer a cancer rate 4 times higher than in the general population. Breast cancer is the most frequent malignant […]
Published: Mar 29, 2013 By Nancy Walsh , Staff Writer, MedPage Today Full Story: http://www.medpagetoday.com/OBGYN/HRT/38162 Action Points Note that this observational cohort study demonstrated an increased risk of invasive breast cancers among women taking estrogen-plus-progestin hormone replacement therapy (HRT) after menopause. Be aware that the overall incidence of breast cancer in users of HRT was […]
Ronald Grisanti D.C., D.A.B.C.O., D.A.C.B.N., M.S. Full Article: http://www.yourmedicaldetective.com/public/1117.cfm Wouldn’t it be great if medical science discovered a way to detect breast cancer much sooner and more accurately and best of all without having to have your breast painfully compressed via a mammogram? Early breast cancer detection can significantly improve survival rates. However, current diagnostic […]
J. Natl. Cancer Inst. 2013 Sep 03;[EPub Ahead of Print], N Hou, S Hong, W Wang, OI Olopade, JJ Dignam, D TAKE-HOME MESSAGE In this retrospective analysis examining the impact of hormone replacement therapy (HRT) on the incidence of breast cancer, authors determined that race, body mass index, and breast density each influenced the risk […]